Corcept Therapeutics Incorporated annual gross profit for fiscal 2025 was $748 million, an increase of 12.7% from $664 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gross Profit | $748M | $664M | $476M | $396M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $162M | $200M | $203M | $191M | $155M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CORT metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All CORT financial statements → Interactive CORT charts →
About TickerBase · Data methodology & sources